Skip to main content

CORRECTION article

Front. Immunol., 16 August 2023
Sec. Viral Immunology
Volume 14 - 2023 | https://doi.org/10.3389/fimmu.2023.1274753

Corrigendum: Cross-reactive humoral and CD4+ T cell responses to Mu and Gamma SARS-CoV-2 variants in a Colombian population

This article is a correction to:

  1. Cross-reactive humoral and CD4+ T cell responses to Mu and Gamma SARS-CoV-2 variants in a Colombian population

    1. Read original article
Fabiola MartelFabiola Martel1Juliana Cuervo-RojasJuliana Cuervo-Rojas2Juana ngelJuana Ángel1Beatriz ArizaBeatriz Ariza3John Mario GonzlezJohn Mario González4Carolina Ramírez-SantanaCarolina Ramírez-Santana5Yeny Acosta-AmpudiaYeny Acosta-Ampudia5Luisa Murcia-SorianoLuisa Murcia-Soriano6Norma MontoyaNorma Montoya7Claudia Cecilia Cardozo-RomeroClaudia Cecilia Cardozo-Romero3Sandra Liliana Valderrama-BeltrnSandra Liliana Valderrama-Beltrán8Magda CepedaMagda Cepeda2Julio Csar CastellanosJulio César Castellanos9Carlos Gmez-RestrepoCarlos Gómez-Restrepo2Federico Perdomo-CelisFederico Perdomo-Celis1Andreu GazquezAndreu Gazquez10Alexandria DicksonAlexandria Dickson10James D. BrienJames D. Brien10Jos MateusJosé Mateus11Alba GrifoniAlba Grifoni11Alessandro Sette,Alessandro Sette11,12Daniela WeiskopfDaniela Weiskopf11Manuel A. Franco*Manuel A. Franco1*
  • 1Institute of Human Genetics, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia
  • 2Department of Clinical Epidemiology and Biostatistics, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia
  • 3Clinical Laboratory Science Research Group, Clinical Laboratory, Hospital Universitario San Ignacio, Bogotá, Colombia
  • 4Group of Basic Medical Sciences, School of Medicine, Universidad de Los Andes, Bogotá, Colombia
  • 5Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia
  • 6Hospital Universitario Mayor-Méderi, Universidad El Rosario, Bogotá, Colombia
  • 7Head Clinical Laboratory Unit, Clínica del Occidente, Bogotá, Colombia
  • 8Division of Infectious Diseases, Department of Internal Medicine. School of Medicine, Pontificia Universidad Javeriana, Hospital Universitario San Ignacio Infectious Diseases Research Group, Bogotá, Colombia
  • 9General Direction, Hospital Universitario San Ignacio, Bogotá, Colombia
  • 10Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, MO, United States
  • 11Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, United States
  • 12Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, La Jolla, CA, United States

A Corrigendum on
Cross-reactive humoral and CD4+ T cell responses to Mu and Gamma SARS-CoV-2 variants in a Colombian population

by Martel F, Cuervo-Rojas J, Ángel J, Ariza B, González JM, Ramírez-Santana C, Acosta-Ampudia Y, Murcia-Soriano L, Montoya N, Cardozo-Romero CC, Valderrama-Beltrán SL, Cepeda M, Castellanos JC, Gómez-Restrepo C, Perdomo-Celis F, Gazquez A, Dickson A, Brien JD, Mateus J, Grifoni A, Sette A, Weiskopf D and Franco MA (2023). Front. Immunol. 14:1241038. doi: 10.3389/fimmu.2023.1241038

In the published article, there was an error in affiliation 5. Instead of “Center for the Study of Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogota´, Colombia”, it should be “Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: SARS-CoV-2, variants, natural infection, vaccination, antibody, CD4+ T cell, hybrid immunity, breakthrough infections

Citation: Martel F, Cuervo-Rojas J, Ángel J, Ariza B, González JM, Ramírez-Santana C, Acosta-Ampudia Y, Murcia-Soriano L, Montoya N, Cardozo-Romero CC, Valderrama-Beltrán SL, Cepeda M, Castellanos JC, Gómez-Restrepo C, Perdomo-Celis F, Gazquez A, Dickson A, Brien JD, Mateus J, Grifoni A, Sette A, Weiskopf D and Franco MA (2023) Corrigendum: Cross-reactive humoral and CD4+ T cell responses to Mu and Gamma SARS-CoV-2 variants in a Colombian population. Front. Immunol. 14:1274753. doi: 10.3389/fimmu.2023.1274753

Received: 08 August 2023; Accepted: 09 August 2023;
Published: 16 August 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Martel, Cuervo-Rojas, Ángel, Ariza, González, Ramírez-Santana, Acosta-Ampudia, Murcia-Soriano, Montoya, Cardozo-Romero, Valderrama-Beltrán, Cepeda, Castellanos, Gómez-Restrepo, Perdomo-Celis, Gazquez, Dickson, Brien, Mateus, Grifoni, Sette, Weiskopf and Franco. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Manuel A. Franco, mafranco@javeriana.edu.co

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.